What to expect from Westfield Group's information day

Investors have been waiting for 15 weeks for greater insight behind the controversial merger proposal.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors in shopping centre behemoth Westfield Group (ASX: WDC) and Westfield Retail Trust (ASX: WRT) have endured months of uncertainty over the controversial merger proposal that was announced on December 4 last year. However, they could finally be given a little extra clarity on April 2 when the Group's chief financial officer, Peter Allen, hosts an information day for investors and analysts.

The proposal, which would have the two entities' local assets merged to form Scentre Group, while the Group's international assets would be split-off to form Westfield Corporation, has divided the market due to the associated costs. While the Lowy family (the founders of the company) are standing firm on the $1.8 billion it insists is payable by the Trust for management & development rights, analysts and investors are arguing that the costs are too great. Some have even suggested the figure should be reduced by as much as $1 billion.

However, it is understood that the information day will not focus on the costs of the deal, but will address the strategic direction of the proposed Scentre Group. For instance, it is suggested that the split would allow each entity (being Scentre Group and Westfield Corporation) to focus on their own growth stories which would arguably generate greater growth and value for shareholders in the long term.

While the presentation will be held at the iconic Sydney Miranda shopping centre, an explanatory memorandum for the transaction is also due out within the next three weeks, which will provide additional cause for debate.

Foolish takeaway

Although management of both entities have expressed their confidence that the deal will be approved based on its original terms, it seems more likely that the deal will be sweetened more in the Trust's favour in order to win over major shareholders.

While both entities are attractive investment prospects at today's prices, Westfield Group's exposure to international markets makes it the more appealing option. Its shares are currently trading at $10.30 and offer a generous 5% dividend yield.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »